Antimicrob Agents Chemother

1. YAO B-F, Yang Y, Xu S-S, Tang B-H, et al
   Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir.
   Antimicrob Agents Chemother. 2025 Sep 18:e0061425. doi: 10.1128/aac.00614.
   

   >> Share

   
   
2. LODISE TP, Min J, Nathanson BH, Yucel E, et al
   Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA).
   Antimicrob Agents Chemother. 2025;69:e0056925.
   

   >> Share

   
   
3. DE LA PORTE DES VAUX C, Veyrenche N, Silva KD, Chavarot N, et al
   Immunocompromised patients with persistent SARS-CoV-2 viral shedding >/=8 weeks, clinical outcomes, and virological dynamics: a retrospective multicenter cohort study, 2020-2024.
   Antimicrob Agents Chemother. 2025 Sep 26:e0065825. doi: 10.1128/aac.00658.
   

   >> Share

   
   

   
   J Virol

4. CHANG LA, Yeung ST, Warang P, Noureddine M, et al
   Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses.
   J Virol. 2025 Nov 5:e0096525. doi: 10.1128/jvi.00965.
   

   >> Share

   
   
5. PAGE CK, Mubassir MHM, Chopra P, Gay LC, et al
   N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages.
   J Virol. 2025 Nov 5:e0103925. doi: 10.1128/jvi.01039.
   

   >> Share

   
   
6. LIN M-W, Quintela IA, Sablani SS, Lin C-S, et al
   Recent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses.
   J Virol. 2025 Nov 4:e0148425. doi: 10.1128/jvi.01484.
   

   >> Share

   
   

   
   PLoS One

7. SHARAFEDDIN SF, Chehade Z, Sayed SE, Salloum D, et al
   The effect of environmental stressors on anti-mullerian hormone levels in Lebanese women: a retrospective study.
   PLoS One. 2025;20:e0336016.
   

   >> Share

   
   
8. BIRCH ON, Par SC, Greaves JC
   Detection and quantification of key dental pathogens through wastewater monitoring.
   PLoS One. 2025;20:e0328420.
   

   >> Share

   
   
9. TETTEH JE, Owusu Junior P
   Co-movement between stock markets in advanced economies and Africa in times of uncertainty: A time-frequency domain approach.
   PLoS One. 2025;20:e0334325.
   

   >> Share

   
   
10. TRAN H, Berke O, Ricker N, Poljak Z, et al
    Evaluating machine learning approaches for host prediction using H3 influenza genomic data.
    PLoS One. 2025;20:e0336142.
    

    >> Share

    
    
11. AYOUNI I, Githaiga JN, Amponsah-Dacosta E, Kagina BM, et al
    Adapting the WHO Behavioural and Social Drivers of Vaccination (BeSD) tools and Vaccination Attitudes Examination (VAX) scale for pregnant women in South Africa: Insights from a mixed-methods pilot study.
    PLoS One. 2025;20:e0334854.
    

    >> Share

    
    
12. JURKOWICZ M, Solomovich M, Leibovitz E, Keller N, et al
    Clinical characteristics, outcomes, and subtype diversity in hospitalized human rhinovirus (HRV) patients.
    PLoS One. 2025;20:e0335739.
    

    >> Share

    
    
13. RHODES S, Douglas C
    Experiences of accessing primary care by those living with long Covid in New Zealand: A qualitative analysis.
    PLoS One. 2025;20:e0324489.
    

    >> Share

    
    
14. PRENTIS J, Radhakrishnan A, Kaner E, Nandhra S, et al
    Telehealth Exercise Training in Peripheral Arterial Disease (TEXTPAD) study: A pilot randomised controlled trial in socioeconomically disadvantaged populations.
    PLoS One. 2025;20:e0327633.
    

    >> Share

    
    
15. MILLA MN, Belanger JJ, Louis WR, Arifin HH, et al
    The 3N Model and collective support for extreme measures to combat COVID-19.
    PLoS One. 2025;20:e0335241.
    

    >> Share

    
    
16. LORETI G, Vottero P, Olivetti EC, Vezzetti E, et al
    Delineating SARS-CoV-2 spike protein and antibodies interaction interfaces via siamese neural networks: A geometric and image-based analysis.
    PLoS One. 2025;20:e0335270.
    

    >> Share

    
    
17. ALOSSAIMI MA, Abdel Bar FM, Elekhnawy E, ElNaggar MH, et al
    Antibacterial and antiviral potential of harmalacidine hydrochloride, a beta-carboline alkaloid, against respiratory tract pathogens: Staphylococcus aureus and H1N1 influenza virus.
    PLoS One. 2025;20:e0335014.
    

    >> Share

    
    
18. SUN J, Wu M, Li J, Bi C, et al
    Effects of COVID-19 pandemic lockdowns on college students' physical fitness: A comparative study.
    PLoS One. 2025;20:e0335309.
    

    >> Share

    
    
19. LORENZ E, Amuasi J, Randrianarisoa T, Rasamoelina T, et al
    Two-stage cluster sampling to assess SARS-CoV-2 seroprevalence without pre-enumeration: An example from Madagascar.
    PLoS One. 2025;20:e0334627.
    

    >> Share

    
    
20. THACHER JD, Vilhelmsson A, Tottenborg SS, Bonde JPE, et al
    Occupational risk of COVID-19 related hospital admission in Skane, Sweden: A register-based cohort study.
    PLoS One. 2025;20:e0335662.
    

    >> Share

    
    
21. POWELL A, Van Hout MC, Connors D, Montgomery C, et al
    A thematic analysis of flu vaccine hesitance in ethnically minoritised communities in Liverpool.
    PLoS One. 2025;20:e0333602.
    

    >> Share

    
    
22. KONISHI K, Yamamoto S, Sada RM, Asano K, et al
    Research to evaluate safety and impact of long COVID intervention with Ensitrelvir for National Cohort (RESILIENCE Study): A protocol for a randomized, double-blind, placebo-controlled trial.
    PLoS One. 2025;20:e0335609.
    

    >> Share

    
    
23. GONZALEZ-TORRES C, Lera L, Lizana PA
    Association between obesity and psychological distress in the Chilean population during the COVID-19 pandemic: Social Wellbeing Survey 2021.
    PLoS One. 2025;20:e0333697.
    

    >> Share

    
    
24. LEI ZY, Zhang XM, Han JL, Xue JG, et al
    Integrating genomic epidemiology and deep mutational scanning data for prevalence forecasting of SARS-CoV-2 Omicron lineages.
    PLoS One. 2025;20:e0335520.
    

    >> Share

    
    
25. YEETHO P, Chaiviboontham S, Sumdaengrit B
    The relationships between symptom severity post COVID-19, stress, social support and adaptation in patients with COVID-19 after discharge from the hospital.
    PLoS One. 2025;20:e0327825.
    

    >> Share

    
    
26. MEDDAR JM, Mann D, Schwartz M, Park HG, et al
    Associations between remote patient monitoring and uncontrolled blood pressure among patients diagnosed with hypertension: Exploring variations by race/ethnicity.
    PLoS One. 2025;20:e0334887.
    

    >> Share

    
    
27. LUO W, Wu X, Li R, Fitzpatrick M, et al
    Variant patterns and influence of inter-regional travel during the SARS-CoV-2 expansion in South Africa.
    PLoS One. 2025;20:e0329621.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

28. LI J, Wang M, Yang Y, Zhang L, et al
    Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head.
    Proc Natl Acad Sci U S A. 2025;122:e2503008122.
    

    >> Share

    
    
29. HARMAND TJ, Pietrok L, Rich H, Deshycka R, et al
    A multivalent nanobody-drug conjugate to prevent and treat influenza virus infections.
    Proc Natl Acad Sci U S A. 2025;122:e2409565122.
    

    >> Share

    
    
30. CHO E, Davis MA, Nowak JA, Izzo M, et al
    Modulating antigen processing through metal-organic frameworks to bias adaptive immunity.
    Proc Natl Acad Sci U S A. 2025;122:e2409555122.
    

    >> Share

    
    

    
    Vaccine

31. BATMUNKH T, Neal EFG, Amraa O, Mazarakis N, et al
    Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial.
    Vaccine. 2025;66:127840.
    

    >> Share

    
    
32. HORA R, Ray A, Kumari A, Dutta M, et al
    Exploring the predictors for the uptake of Respiratory Syncytial Virus (RSV) vaccine under the immunization programme in India.
    Vaccine. 2025;66:127827.
    

    >> Share

    
    
33. GE Y, Zahid A, Kuchur R, Martinez L, et al
    Using machine learning models to predict vaccine hesitancy: a showcase of COVID-19 vaccine hesitancy in rural populations during the pandemic.
    Vaccine. 2025;66:127799.
    

    >> Share

    
    
34. NICHOLLS EJ, Onyango D, Kolodin V, Ottaway Z, et al
    The social lives of the SARS-CoV-2 vaccines: A qualitative study of vaccine understandings and decision-making among people of Black ethnicities in London, UK.
    Vaccine. 2025;66:127802.
    

    >> Share

    
    
35. DOMINGO JL
    Differentiating COVID-19 vaccine-related adverse events from long COVID: A comprehensive review of clinical manifestations, pathophysiology, and diagnostic approaches.
    Vaccine. 2025;66:127842.
    

    >> Share

    
    
36. DE MELO ARAUJO AC, Frugoli AG, de Sena Goncalves JE, Percio J, et al
    Monitoring strategies after the incorporation of vaccines into national immunization programs: a systematic review.
    Vaccine. 2025;66:127850.
    

    >> Share

    
    
37. YAMAGUCHI Y, Amiya S, Inokuchi S, Nagao S, et al
    Distinct trajectories of humoral immune responses after SARS-CoV-2 mRNA vaccination in autoimmune inflammatory rheumatic diseases: A group-based trajectory analysis.
    Vaccine. 2025 Oct 12:127771. doi: 10.1016/j.vaccine.2025.127771.
    

    >> Share

    
    
38. CIMA MJ, Joshua C, Zohoori N, Porter A 3rd, et al
    Hesitancy towards routine childhood vaccinations before and after the COVID-19 pandemic in Arkansas.
    Vaccine. 2025;66:127834.
    

    >> Share

    
    
39. SALINES M, Andraud M, Scoizec A, Schmitz A, et al
    To what extent may the duck population be protected after vaccination against highly pathogenic avian influenza? Contributions from a modelling approach and French field data.
    Vaccine. 2025;68:127905.
    

    >> Share

    
    
40. MORRIS SE, O'Halloran A, Sundaresan D, Dawood FS, et al
    Heterogeneity in seasonal influenza vaccination opportunity and disease risk during pregnancy and in infants <6 months.
    Vaccine. 2025;68:127887.
    

    >> Share

    
    
41. LIU D, Zhang Y, Lei J, Li J, et al
    Influenza, pneumococcal, COVID-19 vaccine willingness and uptake with influencing factors in 38,184 chinese older adults in 2022: a nationwide cross-sectional study.
    Vaccine. 2025;68:127961.
    

    >> Share

    
    
42. SHAMSRIZI P, Eitze S, Heinemeier D, Tanzer AS, et al
    Post-pandemic questions in vaccination counseling: Two qualitative analyses of open-ended responses comparing hypothetical and novel vaccines.
    Vaccine. 2025;66:127823.
    

    >> Share

    
    

    
    Virology

43. MELLACE M, Ceniti C, Borrelli L, Tilocca B, et al
    Viral protein mutations enabling mammalian adaptation in Avian Influenza A viruses: Strategies for zoonotic risk mitigation and future perspectives.
    Virology. 2025;614:110731.
    

    >> Share

    
    
44. WANG A, Hu J, Zhang Q, Zhang Y, et al
    The antiviral activity of interferon-stimulated genes (ISGs) in influenza A virus infection.
    Virology. 2025;614:110728.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share